{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dipyridamole", "query": { "intervention": "Dipyridamole" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 29, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dipyridamole&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T00:49:33.958Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01781611", "title": "Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "extended release dipyridamole 200mg/aspirin 25mg", "type": "DRUG" }, { "name": "81mg aspirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oklahoma Medical Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 18, "start_date": "2013-02", "completion_date": "2017-11", "has_results": true, "last_update_posted_date": "2020-11-25", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01781611" }, { "nct_id": "NCT04424901", "title": "Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19 Pneumonia", "Vascular Complications" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dipyridamole Tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UConn Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2020-05-03", "completion_date": "2022-04-24", "has_results": true, "last_update_posted_date": "2023-04-21", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04424901" }, { "nct_id": "NCT00551707", "title": "Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "CRx-102 (2.7/180)", "type": "DRUG" }, { "name": "prednisolone", "type": "DRUG" }, { "name": "dipyridamole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "CRx-102 (2.7/360)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zalicus", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2007-10", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2014-04-29", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00551707" }, { "nct_id": "NCT00465270", "title": "Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cryptogenic Stroke" ], "interventions": [ { "name": "AMPLATZER PFO Occluder", "type": "DEVICE" }, { "name": "Standard of Care - Medical Management", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 980, "start_date": "2003-08", "completion_date": "2016-05", "has_results": true, "last_update_posted_date": "2019-02-18", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00465270" }, { "nct_id": "NCT00521989", "title": "CRx-102 Osteoarthritis Multicenter Evaluation Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "CRx-102 (2.7/90)", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "CRx-102 (2.7/180)", "type": "DRUG" }, { "name": "CRx-102 (2.7/360)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zalicus", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 279, "start_date": "2007-08", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2014-04-29", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 57, "location_summary": "Huntsville, Alabama • Chandler, Arizona • Mesa, Arizona + 54 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tuscon", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521989" }, { "nct_id": "NCT00276146", "title": "Dipyridamole/Magnesium To Improve Sickle Cell Hydration", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia, Sickle Cell" ], "interventions": [ { "name": "oral dipyridamole, oral magnesium, or a combination of both", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": "2005-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-08-07", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 3, "location_summary": "Detroit, Michigan • Cincinnati, Ohio", "locations": [ { "city": "Detroit", "state": "Michigan" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00276146" }, { "nct_id": "NCT01179230", "title": "Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Myocardial Ischemia", "Heart Disease" ], "interventions": [ { "name": "SPECT imaging", "type": "OTHER" }, { "name": "PET imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Hartford Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 136, "start_date": "2005-01", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2015-03-23", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 5, "location_summary": "Huntsville, Alabama • Hartford, Connecticut • Kansas City, Missouri + 2 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Fargo", "state": "North Dakota" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01179230" }, { "nct_id": "NCT00003018", "title": "S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "dipyridamole", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "mitomycin C", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "1997-09", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 84, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 54 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003018" }, { "nct_id": "NCT00808314", "title": "Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Rest/Dipyridamole Stress Rb-82 Myocardial Perfusion PET/CT", "type": "DRUG" }, { "name": "Rest/Lexiscan(TM) Stress Rb-82 Myocardial Perfusion PET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cardiovascular Imaging Technologies", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "35 Years to 90 Years" }, "enrollment_count": 32, "start_date": "2008-12", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2012-08-02", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00808314" }, { "nct_id": "NCT00760708", "title": "Circulating Adenosine Levels Before and After Intravenous (IV) Persantine", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ischemia", "Coronary Disease" ], "interventions": [], "intervention_types": [], "sponsor": "UConn Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 221, "start_date": "2005-09", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2019-05-14", "last_synced_at": "2026-09-05T00:49:33.958Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00760708" } ] }